[go: up one dir, main page]

AU2003216382A8 - Idothyronine compositions - Google Patents

Idothyronine compositions

Info

Publication number
AU2003216382A8
AU2003216382A8 AU2003216382A AU2003216382A AU2003216382A8 AU 2003216382 A8 AU2003216382 A8 AU 2003216382A8 AU 2003216382 A AU2003216382 A AU 2003216382A AU 2003216382 A AU2003216382 A AU 2003216382A AU 2003216382 A8 AU2003216382 A8 AU 2003216382A8
Authority
AU
Australia
Prior art keywords
idothyronine
compositions
idothyronine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003216382A
Other versions
AU2003216382A1 (en
Inventor
Thomas Piccariello
Lawrence P Olon
Randal J Kirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New River Pharmaceuticals Inc
Original Assignee
New River Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/136,433 external-priority patent/US7163918B2/en
Priority claimed from US10/156,527 external-priority patent/US7060708B2/en
Application filed by New River Pharmaceuticals Inc filed Critical New River Pharmaceuticals Inc
Publication of AU2003216382A1 publication Critical patent/AU2003216382A1/en
Publication of AU2003216382A8 publication Critical patent/AU2003216382A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003216382A 2002-02-22 2003-02-24 Idothyronine compositions Abandoned AU2003216382A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US35838102P 2002-02-22 2002-02-22
US60/358,381 2002-02-22
US36625802P 2002-03-22 2002-03-22
US60/366,258 2002-03-22
US10/136,433 2002-05-02
US10/136,433 US7163918B2 (en) 2000-08-22 2002-05-02 Iodothyronine compositions
US10/156,527 2002-05-29
US10/156,527 US7060708B2 (en) 1999-03-10 2002-05-29 Active agent delivery systems and methods for protecting and administering active agents
PCT/US2003/005526 WO2003072047A2 (en) 2002-02-22 2003-02-24 Idothyronine compositions

Publications (2)

Publication Number Publication Date
AU2003216382A1 AU2003216382A1 (en) 2003-09-09
AU2003216382A8 true AU2003216382A8 (en) 2003-09-09

Family

ID=27767913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003216382A Abandoned AU2003216382A1 (en) 2002-02-22 2003-02-24 Idothyronine compositions

Country Status (2)

Country Link
AU (1) AU2003216382A1 (en)
WO (1) WO2003072047A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163668A0 (en) * 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Use of peptide-drug conjugation to reduce inter-subject variability ofdrug serum levels
EP2316469A1 (en) * 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
CN107561168A (en) * 2016-06-30 2018-01-09 山东新时代药业有限公司 A kind of analyzing detecting method of Pegylation insulin secretion accelerating peptide analog

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489165A (en) * 1983-01-24 1984-12-18 Becton Dickinson And Company Chromogenic tracers for use in an assay
US4719182A (en) * 1985-03-18 1988-01-12 Eastman Kodak Company Fluorescent labels and labeled species and their use in analytical elements and determinations
DE3628795A1 (en) * 1986-08-25 1988-03-03 Hoechst Ag NEW THYRONE DERIVATIVES
US5352803A (en) * 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
JPH08507686A (en) * 1993-03-09 1996-08-20 アボツト・ラボラトリーズ Genetically engineered enzymes and their conjugates for diagnostic assays
US6342225B1 (en) * 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US5910569A (en) * 1994-11-22 1999-06-08 Lotus Biochemical Corporation Iodothyronine polymers
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine

Also Published As

Publication number Publication date
AU2003216382A1 (en) 2003-09-09
WO2003072047A3 (en) 2004-06-17
WO2003072047A2 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
GB0212062D0 (en) Jetable compositions
IL165372A0 (en) Immunodenic compositions
GB0224415D0 (en) Compositions
GB0220467D0 (en) Composition
GB0213638D0 (en) Composition
GB0318894D0 (en) Composition
GB0208609D0 (en) Compositions
GB0203421D0 (en) Composition
GB0227244D0 (en) Composition
GB0208608D0 (en) Composition
GB0221894D0 (en) Compositions
GB0203280D0 (en) Anti-glycolytic composition
AU2003269904A8 (en) Antigen-polymer compositions
GB0203395D0 (en) Compositions
GB0203396D0 (en) Compositions
GB0211924D0 (en) Composition
GB0229808D0 (en) Novel compositions
GB0218241D0 (en) Composition
GB0230274D0 (en) Composition
GB0217366D0 (en) Compositions
EP1495751A4 (en) Hairdye composition
GB2394114B (en) Compositions
AU2003216382A8 (en) Idothyronine compositions
GB0228540D0 (en) Novel compositions
GB0213767D0 (en) Composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase